News
The firm implemented the change after an IRB reviewed initial pharmacokinetic data from the first two patients treated in the trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback